Novel HPV detection with high sensitivity and specificity for cervical cancer screening

Abstract

Human papillomaviruses (HPVs) are small viruses that contain double-stranded DNA. There are about 200 distinct strains, each of which has been related to a range of health concerns. These strains are divided into two categories: low and high risk. There are various ways to detect HPV, including PCR, hybrid capture assays, signal amplification, DNA microarrays, and next-generation sequencing. It is important to note that the effectiveness of commercially available detection kits varies, which can influence how accurately a diagnosis is obtained. While PCR-based procedures can produce false positives, nucleic acid hybridization kits have poorer sensitivity and specificity. These methods also have their own set of obstacles, such as the risk of contamination and financial considerations. Furthermore, clinic visits for sample collection and processing cause privacy issues for many women, resulting in refusal to screen. In our latest investigation on innovative HPV detection methodologies, we started by gathering all DNA sequences from pathologically significant HPV strains. After piecing together and aligning these sequences, we identified specific areas that were perfect for hybridization. This breakthrough allowed us to develop a quick and accurate method for detecting HPV. However, we soon realized that traditional HPV detection kits had their drawbacks; they only picked up a limited number of HPV strains and often missed important variants due to changes in the genomic sequences. To tackle this challenge, we focused on finding common sequences that all major pathological significant HPV strains share. We then designed several probes aimed at these sequences, which successfully hybridized, enhancing our detection capabilities and allowing for a more thorough identification of HPV strains. The findings show a considerable improvement in detection accuracy and breadth compared to previous approaches. To generate a signal from nucleotide hybridized materials, we developed a gold nanoparticle-based approach that can discriminate between single- and double-stranded DNA. Future challenges will require an understanding of how our probe recognizes the viral genome in patient samples that also contain genomic DNA. Color detection has also been addressed, as it offers major complications when producing reliable findings with a home-based system. This component has been meticulously designed to provide dependability and efficacy in a household situation.